Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients (POSIT-HEMI)

January 25, 2024 updated by: Hôpital NOVO

Evaluation of Positioning Protocols With an Adapted Equipment on a Wheelchair in Hemiplegic Patients Following a Stroke

The main purpose of this study is to assess the interest of using wheelchair positioning equipment on the decrease of postural disorders, compared to the standard use of a wheelchair

Study Overview

Detailed Description

The stroke is the main cause of hemiplegia in developed countries. Fifteen percent of people who say they have a stroke need, at home, a wheelchair to get from one room to another. The use of a wheelchair can cause postural disorders which can lead to pain, orthopedic deformity and pressure ulcers.

This study aims to assess the interest of using wheelchair positioning equipment (Seat back, Positioning cushion and Belt) on the decrease of postural disorders.

This decrease will be assessed after a standardized course, performed under three different conditions: with the positioning equipment (Positioning cushion and Seat back), with the positioning equipment and the belt and with the wheelchair alone.

Clinical tool used to assess the decrease is the Seated Postural Control Measure for Adults 2.0 (SPCMA 2.0).

This study, which will be the first prospective, interventional, multicenter, controlled and randomized study, could pave the way for guidelines of good practice, for wheelchair positioning of hemiplegic patients in France

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Aincourt, France, 95510
        • Groupement Hospitalier Intercommunal du Vexin
      • Garche, France, 92380
        • Hôpital Raymond Poincaré
      • Lay-Saint-Christophe, France, 54690
        • Institut Régional de Réadaptation
      • Lille, France, 59260
        • Centre de l'ESPOIR
      • Mantes-la-Jolie, France, 78200
        • Centre de Rééducation L'oiseau Blanc
      • Menucourt, France, 95180
        • Centre de Rééducation et de Réadaptation Fonctionnelles
      • Toulouse, France, 31059
        • Centre Hospitalier Universitaire de Toulouse

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Hemiplegic patient following a stroke
  • Hospitalized in a follow-up and rehabilitative care service, after hospital stays in a MCO service (neurology, neurosurgery or reanimation)
  • With a planned exit from hospital (homecoming, residential care facilities, nursing home, Long Term Care Unit …)
  • Patient whose wheelchair choice should be already done
  • Patient who propels the wheelchair with the valid hand and/or valid foot
  • Written informed consent (IC) obtained
  • Patients with affiliation to the social security system

Exclusion Criteria:

  • Good walk recovery (FAC scale >3)
  • Wheelchair with a double hand rim
  • Patient who cannot use his2 wheelchair independently
  • Cognitive disorders which prevent the ability to well understanding the instructions
  • Other pathology which can interfere with this protocol (Spinal disorder, morbid overweight (BMI>40…)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Use of positioning equipment order 1
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

Materials used for the course :

  1. : Standard Wheelchair
  2. : Standard Wheelchair + Seat back + Positioning cushion
  3. : Standard Wheelchair + Seat back + Positioning cushion + Belt
Experimental: Use of positioning equipment order 2
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

Materials used for the course :

  1. : Standard Wheelchair
  2. : Standard Wheelchair + Seat back + Positioning cushion + Belt
  3. : Standard Wheelchair + Seat back + Positioning cushion
Experimental: Use of positioning equipment order 3
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

Materials used for the course :

  1. : Standard Wheelchair + Seat back + Positioning cushion
  2. : Standard Wheelchair + Seat back + Positioning cushion + Belt
  3. : Standard Wheelchair
Experimental: Use of positioning equipment order 4
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

Materials used for the course :

  1. : Standard Wheelchair + Seat back + Positioning cushion
  2. : Standard Wheelchair
  3. : Standard Wheelchair + Seat back + Positioning cushion + Belt
Experimental: Use of positioning equipment order 5
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

Materials used for the course :

  1. : Standard Wheelchair + Seat back + Positioning cushion + Belt
  2. : Standard Wheelchair
  3. : Standard Wheelchair + Seat back + Positioning cushion
Experimental: Use of positioning equipment order 6
One standardized course is performed 3 times by each patient : one with a standard wheelchair and the 2 other with one or two positioning equipment (Seat back or/and positioning cushion) Each arm differs from the previous by the order of use of the equipment.

Materials used for the course :

  1. : Standard Wheelchair + Seat back + Positioning cushion + Belt
  2. : Standard Wheelchair + Seat back + Positioning cushion
  3. : Standard Wheelchair

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of pelvic posterior tilt
Time Frame: Immediately after the end of the procedure, an average of 1 day

The Primary Outcome Measure is the variation of the Degree of pelvic posterior tilt at the end of the three standardized course. These courses were performed with Standard Wheelchair, Standard Wheelchair + Seat back + Positioning cushion + Belt or with Standard Wheelchair + Seat back + Positioning cushion.

The Degree of pelvic posterior tilt was measured using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)

Immediately after the end of the procedure, an average of 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Variation of Degree of pelvic posterior tilt
Time Frame: Baseline and immediately after the end of the procedure, an average of 1 day
The variation of the Degree of pelvic posterior tilt was measured between the beginning and the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
Baseline and immediately after the end of the procedure, an average of 1 day
Variation of degree of lateral inclination of the torso
Time Frame: Baseline and immediately after the end of the procedure, an average of 1 day
The variation of the degree of lateral inclination of the torso was measured between the beginning and the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
Baseline and immediately after the end of the procedure, an average of 1 day
Variation of the degree of Pelvis obliquity
Time Frame: Baseline and immediately after the end of the procedure, an average of 1 day
The variation of the degree of Pelvis obliquity was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 =moderate and 3 = severe retroversion)
Baseline and immediately after the end of the procedure, an average of 1 day
Degree of lateral inclination of the torso
Time Frame: Immediately after the end of the procedure, an average of 1 day
The degree of lateral inclination of the torso was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
Immediately after the end of the procedure, an average of 1 day
Degree of Pelvis obliquity
Time Frame: Immediately after the end of the procedure, an average of 1 day
The degree of Pelvis obliquity was measured at the end of the three standardized course using the SPCMA 2.0 score (0 = normal, 1 = mild, 2 = moderate and 3 = severe retroversion)
Immediately after the end of the procedure, an average of 1 day
Measure of patient's satisfaction
Time Frame: Immediately after the end of the procedure, an average of 1 day
The satisfaction of patient was measured with a satisfaction questionnaire scale based on ease of movement, wheelchair comfort and pain during the course. For each item, patient ticks : Very satisfied, Satisfied, Neither satisfied or unsatisfied, Unsatisfied or Very unsatisfied
Immediately after the end of the procedure, an average of 1 day
Ability to achieve the whole course
Time Frame: Immediately after the end of the procedure, an average of 1 day
Binary criteria (Yes / No)
Immediately after the end of the procedure, an average of 1 day
Adverse event collect
Time Frame: Immediately after the end of the procedure, an average of 1 day
Total number of adverse event
Immediately after the end of the procedure, an average of 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Nadine Pellegrini, Groupement Hospitalier Intercommunal du Vexin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2020

Primary Completion (Actual)

December 11, 2023

Study Completion (Actual)

December 11, 2023

Study Registration Dates

First Submitted

February 10, 2020

First Submitted That Met QC Criteria

February 12, 2020

First Posted (Actual)

February 13, 2020

Study Record Updates

Last Update Posted (Actual)

January 26, 2024

Last Update Submitted That Met QC Criteria

January 25, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiplegia and/or Hemiparesis Following Stroke

Clinical Trials on Arm 1

3
Subscribe